I’m Live
by lokety on Sep.17, 2006, under Posts

I’ve migrated both www.geocities.com/lokety/ and lokety.blogspot.com to a spanking new paid host:
www.lokety.com and glob.lokety.com
respectively.
Initially there has been problems with FTP publishing to glob.lokety.com from Blogger, which was fixed by using Microsoft Internet Explorer and changing from hostname to IP for the ftp server. I’m not sure which one helped but now I’m facing another problem which I hope this post will fix. Images are still hosted on and referenced from Blogger, but they are supposed to be transferred over to my host along with the HTML files. Let’s see how this goes.
Technorati Tags: hosting, blogger, commercial hosting, ftp publishing, lokety, blog
Related posts:
- lokety 2.0
- Blogger.com Template Tip: Render Previous Post Link At Bottom Of Main Page
- Blogger.com Template Tip Part 2: Render Previous Post Links
lokety 2.0
by lokety on Sep.15, 2006, under Posts
After more than ten years on the World Wide Web, my web sites are going to be commercially hosted.
Watch out for it!
<URL:http://www.geocities.com/lokety>
<URL:http://lokety.blogspot.com>
<URL:http://lokefamily.blogspot.com>
<URL:http://theresachong.blogspot.com>
And some exciting new ones too…
Technorati Tags: website, www, hosting, web site, blog, lokety, yan, 2.0
Related posts:
Cell Therapeutics Up After Positive Xyotax Phase 1 Results
by lokety on Aug.25, 2006, under Posts
Cell Therapeutics stock was up after positive results from 91 percent target achievement rate was reported in the August issue of the American Journal of Clinical Oncology. Twelve patients with esophageal or gastric cancer has been tested with the cancer drug Xyotax.
Dr. Howard Safran of Brown University says that Xyotax may “replace paclitaxel as the most important radiation sensitizer in solid tumors”. If this is true, we may see a future without the need for or less side effects from chemotherapy drugs.
CTIC closed $1.61 on Thursday 24 August 2006.

Technorati Tags: cell therapeutics, ctic, xyotax, results, cancer, tumor, chemotherapy, drug
Related posts:
- Cell Therapeutics to Submit New XYOTAX Drug Trial to FDA
- Cell Therapeutics Signs Deal With Norvatis
- Cell Therapeutics To Suspend Enrollment for PIONEER Drug Trial
